ZimVie Inc. (NASDAQ:ZIMV) Stock Holdings Lifted by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its stake in shares of ZimVie Inc. (NASDAQ:ZIMV) by 66.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 183,419 shares of the company’s stock after acquiring an additional 73,395 shares during the quarter. JPMorgan Chase & Co.’s holdings in ZimVie were worth $2,911,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Segall Bryant & Hamill LLC acquired a new position in shares of ZimVie in the 3rd quarter valued at $891,000. Point72 Asset Management L.P. purchased a new stake in ZimVie during the second quarter valued at about $3,993,000. Barclays PLC boosted its holdings in shares of ZimVie by 338.4% in the third quarter. Barclays PLC now owns 43,437 shares of the company’s stock worth $690,000 after buying an additional 33,529 shares during the period. Geode Capital Management LLC increased its position in shares of ZimVie by 2.4% in the third quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock worth $10,263,000 after acquiring an additional 15,053 shares in the last quarter. Finally, American Century Companies Inc. raised its holdings in shares of ZimVie by 212.8% during the second quarter. American Century Companies Inc. now owns 412,434 shares of the company’s stock valued at $7,527,000 after acquiring an additional 280,565 shares during the period. 95.63% of the stock is owned by institutional investors and hedge funds.

ZimVie Trading Up 1.7 %

ZimVie stock opened at $14.29 on Monday. ZimVie Inc. has a 52 week low of $13.01 and a 52 week high of $22.40. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The firm has a market capitalization of $394.40 million, a price-to-earnings ratio of -1.09 and a beta of 2.11. The company has a 50 day moving average price of $13.96 and a 200 day moving average price of $15.89.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.